Clinical Trial Update: Intravenous AMD3100 for Collection of Autologous Peripheral Blood Stem Cells in Patients With Lymphoma [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update summarizes Phase 1/2 results for intravenous AMD3100 (plerixafor) used to collect autologous peripheral blood stem cells in patients …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hodgkin Lymphoma
• Non-hodgkin Lymphoma

Drugs mentioned

• Mozobil (Plerixafor) (Plerixafor)

Snippet

Sponsor: Washington University School of Medicine | Conditions: Lymphoma, Non-Hodgkin, Hodgkin Disease | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2016-10-28